Image

Role of EEG in Differentiation Between Ischemic and Hemorrhagic Stroke

Role of EEG in Differentiation Between Ischemic and Hemorrhagic Stroke

Recruiting
18-80 years
All
Phase N/A

Powered by AI

Overview

Searching electrical activity registered by EEG in acute ischemic and hemorrhagic stroke and comparing these parameters to the poststroke recovery patterns to investigate the role of EEG as a differentiation tool and as a predictor of post-stroke recovery.

Description

In this study, EEG will be performed on each patient included; within 72 hours of the onset of the stroke. The EEG device will be used within the intended use as described in the user manuals. The electrodes are put on the patient's head, and the EEG signal is recorded for several minutes; the amplifier is used to amplify the EEG signal and reduce artifacts. A complete EEG and data will be collected at baseline and on follow-up to observe the differences in EEG patterns to perform a qualitative assessment of the EEG results.

EEG patterns depend on the size and location of acute ischemic stroke, including generalized or focal slowing or both and epileptiform discharges. Abnormal neuronal activity is determined by comparing a part of the patient's brain not affected by stroke to a part of the patient's brain affected by stroke. Moreover, Abnormal blood flow is interpreted by comparing the abnormal EEG patterns in the areas of infarctions or hemorrhage to the normal brain tissue signals. The aim is to compare electric waveforms from an EEG device between patients with acute ischemic and acute hemorrhagic stroke (at baseline which is within 72 hours of the onset of acute ischemic and acute hemorrhagic stroke and through study completion, an average of 3 to 6 months).

Eligibility

Inclusion Criteria:

  • Age above 18 and below 80 years.
  • Acute Ischemic stroke: ischemic arteria cerebri media infarct confirmed by MRI.
  • Acute Hemorrhagic stroke: spontaneous intraparenchymal bleeding confirmed by CT.
  • Stroke onset <72 hours before expected time of performing EEG.
  • First-ever ischemic stroke.
  • Measurable deficit on the National Institute of Health Stroke Scale (NIHSS).
  • Able to give and sign informed consent.

Exclusion Criteria:

  • Transient Ischemic Attacks (TIAs).
  • Greater than 72 hours past the initial insult.
  • Patients with subarachnoid haemorrhage, traumatic haemorrhage (epidural/subdural bleeding), cerebral venous sinus thrombosis, indication for urgent neurosurgical intervention.
  • History of other central nervous system diseases.
  • Any signs unfit for MRI/EEG scan.
  • Injury or active infection of electrode cap placement area.
  • Claustrophobia; recognition disorder.
  • Known skull defect or head trauma.
  • Previous neurological procedure (metallic implant, brain pace, cranial operation history).
  • Significant physical impairment that would restrict the ability to use the portable EEG devices.
  • Presence of malignancy or systemic rheumatic disease
  • Non-stroke disease or lesion affecting the sensorimotor system.
  • Alcohol or drug addiction.
  • Presence of pump/shunt.
  • Presence of Malignancy.
  • Presence of severe cognitive impairment.
  • History of epilepsy or taking medication due to epilepsy.

Study details
    Acute Ischemic Stroke
    Acute Haemorrhagic Stroke

NCT06984965

Assiut University

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.